3beta-hydroxy-7-oxo-5-cholestenoic acid
| Catalog Number | BL-M001321 |
| CAS Number | 1246298-64-5 |
| Description | 3beta-hydroxy-7-oxo-5-cholestenoic acid, an intriguing derivative extracted from bile acids, is widely investigated for its promising therapeutic potentials in addressing liver afflictions such as cholestasis and nonalcoholic fatty liver disease. Its biochemical properties suggest a novel avenue for groundbreaking research and clinical interventions in hepatology. |
 | |
| IUPAC Name | (2R,6R)-6-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid |
| Synonyms | (25R)-cholest-5-en-26-oic acid, 3beta-hydroxy-7-oxo |
| Molecular Weight | 430.62 |
| Molecular Formula | C27H42O4 |
| Boiling Point | 590.5±33.0 °C at 760 mmHg |
| Purity | >99% |
| Density | 1.1±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 75.31%, H 9.83%, O 14.86% |
| Canonical SMILES | CC(CCCC(C)C(=O)O)C1CCC2C1(CCC3C2C(=O)C=C4C3(CCC(C4)O)C)C |
| InChI | InChI=1S/C27H42O4/c1-16(6-5-7-17(2)25(30)31)20-8-9-21-24-22(11-13-27(20,21)4)26(3)12-10-19(28)14-18(26)15-23(24)29/h15-17,19-22,24,28H,5-14H2,1-4H3,(H,30,31)/t16-,17-,19+,20-,21+,22+,24+,26+,27-/m1/s1 |
| InChI Key | QOEPZHFZXUROGV-BXDHRDAUSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
